Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials

In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the c...

Full description

Saved in:
Bibliographic Details
Published inStatistics in medicine Vol. 33; no. 29; pp. 5041 - 5056
Main Authors Shoben, Abigail B., Emerson, Scott S.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 20.12.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0277-6715
1097-0258
1097-0258
DOI10.1002/sim.6306

Cover

Loading…
Abstract In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power. Copyright © 2014 John Wiley & Sons, Ltd.
AbstractList In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power.
In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power. Copyright © 2014 John Wiley & Sons, Ltd.
In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power.In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power.
Author Shoben, Abigail B.
Emerson, Scott S.
Author_xml – sequence: 1
  givenname: Abigail B.
  surname: Shoben
  fullname: Shoben, Abigail B.
  email: Correspondence to: Abigail B. Shoben, Division of Biostatistics, College of Public Health, The Ohio State University, 249 Cunz Hall, 1841 Neil Ave, Columbus, OH, 43210, U.S.A., ashoben@cph.osu.edu
  organization: Division of Biostatistics, College of Public Health, The Ohio State University, OH, 43210, Columbus, U.S.A
– sequence: 2
  givenname: Scott S.
  surname: Emerson
  fullname: Emerson, Scott S.
  organization: Department of Biostatistics, University of Washington, WA, 98195, Seattle, U.S.A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25224560$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi1URLcFiV-ALHHhksUfsZ0cUaEfUlkOfJSb5U0mW5fE2dqOSnvnfzPbbYtAwGXGGj_zambePbITxgCEPOdszhkTr5Mf5loy_YjMOKtNwYSqdsiMCWMKbbjaJXspXTDGuRLmCdkVSohSaTYjP774sXfZjyHRsaP5HKgPLawBQ8j4biIMm5dLaRrWG5BenUOgU_JhRVcQILre30BLIWU_oBSW4XK61cR-2o9h5fPU-uB6uorjtKYJ_1HTYyFHjOkpedxhgmd3eZ98Pnz36eC4OP1wdHLw5rRoykrpouWubJdl3VSy09wx0ZRS6Up0UHetK5esbI3jSnay5A7KJW8cAGN1y7pK1E0n98mrre46jjhCynbwqYG-dwHGKVmuhVC1YlIh-vIP9GKcIu6QrOC6xnmMlv-jUAtnFnXFkXpxR03LAVq7jnioeG3vbUBgvgWaOKYUobONz7cXzNH53nJmNz5b9NlufP61yEPDveZf0GKLXvkerv_J2Y8n73_nfcrw_YF38ZvVRhplzxZH9uvbM3O4WEhs_QkBi8fh
CODEN SMEDDA
CitedBy_id crossref_primary_10_1177_0962280218773115
crossref_primary_10_1093_biomtc_ujaf020
crossref_primary_10_1177_17407745241304284
Cites_doi 10.2307/2533218
10.2307/2532890
10.1080/01621459.1997.10473654
10.1001/jama.300.15.1774
10.1080/03610919408813210
10.2307/2533336
10.2307/2343787
10.2307/2530245
10.1093/biomet/73.1.13
10.1093/biomet/82.2.407
10.1080/01621459.1997.10473655
10.1093/biomet/83.4.779
10.1093/biomet/64.2.191
ContentType Journal Article
Copyright Copyright © 2014 John Wiley & Sons, Ltd.
Copyright Wiley Subscription Services, Inc. Dec 20, 2014
Copyright_xml – notice: Copyright © 2014 John Wiley & Sons, Ltd.
– notice: Copyright Wiley Subscription Services, Inc. Dec 20, 2014
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1002/sim.6306
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Statistics
Public Health
EISSN 1097-0258
EndPage 5056
ExternalDocumentID 3510083751
25224560
10_1002_sim_6306
SIM6306
ark_67375_WNG_XDW7FNN3_6
Genre article
Journal Article
Feature
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABOCM
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACPOU
ACRPL
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AFBPY
AFFPM
AFGKR
AFWVQ
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
ROL
RX1
RYL
SUPJJ
SV3
TN5
UB1
V2E
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WOHZO
WQJ
WXSBR
WYISQ
XBAML
XG1
XV2
ZZTAW
~IA
~WT
AEUQT
AFPWT
RWI
WRC
WUP
WWH
AAYXX
AEYWJ
AGQPQ
AGYGG
AMVHM
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
ID FETCH-LOGICAL-c4856-d1a4db49c83f61a02c435682fe9fda4b04d7a153f341ae4b1caee009d0f829cf3
IEDL.DBID DR2
ISSN 0277-6715
1097-0258
IngestDate Thu Jul 10 20:43:57 EDT 2025
Sat Aug 16 22:20:57 EDT 2025
Sun Jul 13 03:46:42 EDT 2025
Thu Apr 03 07:04:08 EDT 2025
Thu Apr 24 23:02:57 EDT 2025
Tue Jul 01 03:28:06 EDT 2025
Wed Jan 22 16:19:25 EST 2025
Wed Mar 05 09:12:29 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 29
Keywords group sequential methods
independent increments
clinical trials
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
Copyright © 2014 John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4856-d1a4db49c83f61a02c435682fe9fda4b04d7a153f341ae4b1caee009d0f829cf3
Notes istex:53B3DED3E8970202F8F7C4296DA84A913DD7EBC9
ark:/67375/WNG-XDW7FNN3-6
ArticleID:SIM6306
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 25224560
PQID 1628562981
PQPubID 48361
PageCount 16
ParticipantIDs proquest_miscellaneous_1622595035
proquest_journals_2169485763
proquest_journals_1628562981
pubmed_primary_25224560
crossref_citationtrail_10_1002_sim_6306
crossref_primary_10_1002_sim_6306
wiley_primary_10_1002_sim_6306_SIM6306
istex_primary_ark_67375_WNG_XDW7FNN3_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20 December 2014
PublicationDateYYYYMMDD 2014-12-20
PublicationDate_xml – month: 12
  year: 2014
  text: 20 December 2014
  day: 20
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Statistics in medicine
PublicationTitleAlternate Statist. Med
PublicationYear 2014
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Insightful Corporation. S+seqtrial. Insightful Corporation: Seattle, Washington, 2002.
Lee SJ, Kim K, Tsiatis AA. Repeated significance testing in longitudinal clinical trials. Biometrika 1996; 83:779-789.
Jennison C, Turnbull B. Group Sequential Methods with Applications to Clinical Trials. CRC Press: Boca Raton, FL, 2000.
Jennison C, Turnbull BW. Group sequential analysis incorporating covariate information. Journal of the American Statistical Association 1997; 92:1330-1341.
Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A, General 1969; 132:235-244.
Crowder M. On the use of working correlation matrix in using generalized linear models for repeated measures. Biometrika 1995; 82:407-410.
O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556.
Fitzmaurice GM. A caveat concerning independence estimating equations with multivariate binary data. Biometrics 1995; 51:309-317.
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
Mancl LA, Leroux BG. Efficiency of regression estimates for clustered data. Biometrics 1996; 52:500-511.
Scharfstein DO, Tsiatis AA, Robins JM. Semiparametric efficiency and its implications on the design and analysis of group sequential studies. Journal of the American Statistical Association 1997; 92:1342-1350.
Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-200.
The MPS Research Unit. PEST (Planning and Evaluation of Sequential Trials). The MPS Research Unit, The University of Reading, Reading: U.K., 2000
Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Journal of the American Medical Association 2008; 300(15):1774-1783.
The Cytel Software Corp. East. The Cytel Software Corp: Cambridge, Massachusetts, 2000.
Pepe MS, Anderson GL. A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Communications in Statistics Simulation and Computation 1994; 23:939-951.
Lipsitz SR, Fitzmaurice GM, Orav EJ, Laird NM. Performance of generalized estimating equations in practical situations. Biometrics 1994; 50:270-278.
1995; 51
1995; 82
1979; 35
1997; 92
1986; 73
2000
1994; 23
1996; 83
1996; 52
1977; 64
2002
2008; 300
1994; 50
1969; 132
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
The Cytel Software Corp (e_1_2_8_2_1) 2000
The MPS Research Unit (e_1_2_8_3_1) 2000
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_10_1
e_1_2_8_11_1
e_1_2_8_12_1
Jennison C (e_1_2_8_16_1) 2000
Insightful Corporation (e_1_2_8_4_1) 2002
References_xml – reference: Mancl LA, Leroux BG. Efficiency of regression estimates for clustered data. Biometrics 1996; 52:500-511.
– reference: Scharfstein DO, Tsiatis AA, Robins JM. Semiparametric efficiency and its implications on the design and analysis of group sequential studies. Journal of the American Statistical Association 1997; 92:1342-1350.
– reference: Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
– reference: Crowder M. On the use of working correlation matrix in using generalized linear models for repeated measures. Biometrika 1995; 82:407-410.
– reference: Lipsitz SR, Fitzmaurice GM, Orav EJ, Laird NM. Performance of generalized estimating equations in practical situations. Biometrics 1994; 50:270-278.
– reference: Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A, General 1969; 132:235-244.
– reference: O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556.
– reference: Jennison C, Turnbull B. Group Sequential Methods with Applications to Clinical Trials. CRC Press: Boca Raton, FL, 2000.
– reference: Jennison C, Turnbull BW. Group sequential analysis incorporating covariate information. Journal of the American Statistical Association 1997; 92:1330-1341.
– reference: The Cytel Software Corp. East. The Cytel Software Corp: Cambridge, Massachusetts, 2000.
– reference: Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Journal of the American Medical Association 2008; 300(15):1774-1783.
– reference: The MPS Research Unit. PEST (Planning and Evaluation of Sequential Trials). The MPS Research Unit, The University of Reading, Reading: U.K., 2000
– reference: Fitzmaurice GM. A caveat concerning independence estimating equations with multivariate binary data. Biometrics 1995; 51:309-317.
– reference: Insightful Corporation. S+seqtrial. Insightful Corporation: Seattle, Washington, 2002.
– reference: Lee SJ, Kim K, Tsiatis AA. Repeated significance testing in longitudinal clinical trials. Biometrika 1996; 83:779-789.
– reference: Pepe MS, Anderson GL. A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Communications in Statistics Simulation and Computation 1994; 23:939-951.
– reference: Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-200.
– volume: 83
  start-page: 779
  year: 1996
  end-page: 789
  article-title: Repeated significance testing in longitudinal clinical trials
  publication-title: Biometrika
– volume: 92
  start-page: 1330
  year: 1997
  end-page: 1341
  article-title: Group sequential analysis incorporating covariate information
  publication-title: Journal of the American Statistical Association
– volume: 300
  start-page: 1774
  issue: 15
  year: 2008
  end-page: 1783
  article-title: High‐dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
  publication-title: Journal of the American Medical Association
– volume: 51
  start-page: 309
  year: 1995
  end-page: 317
  article-title: A caveat concerning independence estimating equations with multivariate binary data
  publication-title: Biometrics
– volume: 52
  start-page: 500
  year: 1996
  end-page: 511
  article-title: Efficiency of regression estimates for clustered data
  publication-title: Biometrics
– year: 2002
– volume: 92
  start-page: 1342
  year: 1997
  end-page: 1350
  article-title: Semiparametric efficiency and its implications on the design and analysis of group sequential studies
  publication-title: Journal of the American Statistical Association
– year: 2000
– volume: 23
  start-page: 939
  year: 1994
  end-page: 951
  article-title: A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data
  publication-title: Communications in Statistics Simulation and Computation
– volume: 82
  start-page: 407
  year: 1995
  end-page: 410
  article-title: On the use of working correlation matrix in using generalized linear models for repeated measures
  publication-title: Biometrika
– volume: 64
  start-page: 191
  year: 1977
  end-page: 200
  article-title: Group sequential methods in the design and analysis of clinical trials
  publication-title: Biometrika
– volume: 73
  start-page: 13
  year: 1986
  end-page: 22
  article-title: Longitudinal data analysis using generalized linear models
  publication-title: Biometrika
– volume: 132
  start-page: 235
  year: 1969
  end-page: 244
  article-title: Repeated significance tests on accumulating data
  publication-title: Journal of the Royal Statistical Society, Series A, General
– volume: 50
  start-page: 270
  year: 1994
  end-page: 278
  article-title: Performance of generalized estimating equations in practical situations
  publication-title: Biometrics
– volume: 35
  start-page: 549
  year: 1979
  end-page: 556
  article-title: A multiple testing procedure for clinical trials
  publication-title: Biometrics
– ident: e_1_2_8_11_1
  doi: 10.2307/2533218
– volume-title: PEST (Planning and Evaluation of Sequential Trials)
  year: 2000
  ident: e_1_2_8_3_1
– ident: e_1_2_8_13_1
  doi: 10.2307/2532890
– ident: e_1_2_8_6_1
  doi: 10.1080/01621459.1997.10473654
– ident: e_1_2_8_17_1
– ident: e_1_2_8_7_1
  doi: 10.1001/jama.300.15.1774
– ident: e_1_2_8_9_1
  doi: 10.1080/03610919408813210
– ident: e_1_2_8_12_1
  doi: 10.2307/2533336
– ident: e_1_2_8_15_1
  doi: 10.2307/2343787
– volume-title: Group Sequential Methods with Applications to Clinical Trials
  year: 2000
  ident: e_1_2_8_16_1
– ident: e_1_2_8_18_1
– ident: e_1_2_8_20_1
  doi: 10.2307/2530245
– ident: e_1_2_8_8_1
  doi: 10.1093/biomet/73.1.13
– ident: e_1_2_8_10_1
  doi: 10.1093/biomet/82.2.407
– volume-title: East
  year: 2000
  ident: e_1_2_8_2_1
– ident: e_1_2_8_5_1
  doi: 10.1080/01621459.1997.10473655
– volume-title: S+seqtrial
  year: 2002
  ident: e_1_2_8_4_1
– ident: e_1_2_8_14_1
  doi: 10.1093/biomet/83.4.779
– ident: e_1_2_8_19_1
  doi: 10.1093/biomet/64.2.191
SSID ssj0011527
Score 2.1621158
Snippet In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5041
SubjectTerms Clinical trials
Clinical Trials, Phase III as Topic - economics
Clinical Trials, Phase III as Topic - ethics
Clinical Trials, Phase III as Topic - statistics & numerical data
Correlation analysis
Epidemiologic Research Design
Estimating techniques
group sequential methods
Humans
independent increments
Longitudinal Studies
Medical statistics
Sampling
Software
Statistics as Topic - methods
Violations
Title Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials
URI https://api.istex.fr/ark:/67375/WNG-XDW7FNN3-6/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsim.6306
https://www.ncbi.nlm.nih.gov/pubmed/25224560
https://www.proquest.com/docview/1628562981
https://www.proquest.com/docview/2169485763
https://www.proquest.com/docview/1622595035
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfQkNAkxEf5KgxkJARP6RLHcZJHBJSB1D4AY5V4sPw5qnXNWFuB9s7_zZ2dBA0VCfGUKL5EtnM-_2zf_Y6QZ5my2vNUJY45m3ChfaJhtZw4IVRhhAUIgfHOk6k4OOTvZ8Ws9arEWJjID9FvuOHICPYaB7jSq_3fpKGr-elI5IFtG121EA996Jmjsi5bK55QijIrOt7ZlO13L16aia5ip_7YBjMvo9Yw7Yxvki9dhaO3yclos9Yjc_EHl-P_tegWudGiUfoyqs9tcsUtB-TapD1vH5DrcVePxmClAdlFbBqpne-Qn5_nTetJRxtPAUnSeZ9Udw33Ju49UsDnoDQoSL9_dUuKvvbH9DgSXs8vnKVI9YHQGR67b5F8HN6niwazKW0sZu6iIf6ERtdvMEsLGhKOrO6Sw_GbT68OkjarQ2J4VYjEZopbzWtT5V5kKmUGEJuomHe1t4rrlNtSgR32ML8qx3VmlHOABG3qK1Ybn98jO8tm6R4Q6nPtvC5rVxjGi8xVtS9roXSR16Z0zA_Ji-4PS9NSnmPmjYWMZM1MQpdL7PIhedpLnkWajy0yz4OS9ALq_ATd4spCHk3fytnro3I8neYSBPc6LZKtRVjJDGNVBaurbGsxywTy9IC1h6r0xTDU8fxGLV2zCZ-AxWqR5sWQ3I_K2deFAY4GLJxCJYOK_bUV8uO7CV4f_qvgI7ILIDGQW7J0j-yszzfuMQCxtX4ShtwvJhoy9g
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELamTYJJiB_lV2GAkRA8pYudxEnEE2KUDtY-wMb6MMmyHXtUKwmsrUB75__mLk6ChoqEeGrUXCLHOZ-_2HffR8gzpgrt4lAFltsiiIV2gYav5cAKoRIjCoAQWO88nojRUfxumkw3yMu2FsbzQ3QLbjgy6niNAxwXpHd_s4YuZl8GIkK67S0U9Eb5gr0PHXcUa_VacY9SpCxpmWdDvtteeWku2sJu_bEOaF7GrfXEM7xBTtom-3yTs8FqqQfm4g82x_98ppvkegNI6SvvQbfIhi175Mq42XLvkWt-YY_6eqUe2UZ46tmdb5Ofn2ZVk0xHK0cBTNJZp6u7hGPjlx8pQHTwGzSk3z_bkmK6_Sk99ZzXswtbUGT7QPQMf9tvnn8crqfzCgWVVgWKd9G6BIX67G-ITHNaa44s7pCj4ZvD16OgEXYITJwlIiiYigsd5yaLnGAq5AZAm8i4s7krVKzDuEgVhGIHU6yysWZGWQtgsAhdxnPjortks6xKe59QF2nrdJrbxPA4YTbLXZoLpZMoN6nlrk9etK9Ymob1HMU35tLzNXMJXS6xy_vkaWf51TN9rLF5XntJZ6DOzzAzLk3k8eStnO4dp8PJJJJguNO6kWyCwkIyLFcVPM_Y2tOcCaTqgYAPTelOw2jHLRxV2mpV3wK-V5MwSvrknvfOri0coDTA4RAaWfvYX59Cftwf4--DfzV8Qq6ODscH8mB_8v4h2QbMWHNd8nCHbC7PV_YR4LKlflyPv18iczcQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfQJk2TEB_lqzDASAie0iWO4ySPiFE2oBUCxirtwfLnqFaasbYC7Z3_m7s4CRoqEuIpUXKJHOfu_LN99ztCnibKas9jFTnmbMSF9pGG2XLkhFCZERYgBOY7j8Zi_5C_mWSTJqoSc2ECP0S34IaWUftrNPAz63d_k4Yupl8HIkW27U0uwFYQEH3oqKOStlwrblGKPMla4tmY7bZPXhqKNrFXf6zDmZdhaz3uDK-T47bFIdzkdLBa6oG5-IPM8f8-6Qa51sBR-iLoz01yxc17ZGvUbLj3yNWwrEdDtlKPbCM4DdzOt8jPz9OqCaWjlacAJem0q6q7hHMTFh8pAHTQGhSk37-4OcVg-xN6EhivpxfOUuT6QOwMl923wD4Oz9NZheWUVhZLd9E6AYWG2G_wSzNaVxxZ3CaHw1efXu5HTVmHyPAiE5FNFLeal6ZIvUhUzAxANlEw70pvFdcxt7kCR-xhgFWO68Qo5wAK2tgXrDQ-vUM25tXc3SPUp9p5nZcuM4xniStKn5dC6SwtTe6Y75Pn7R-WpuE8x9IbMxnYmpmELpfY5X3ypJM8Czwfa2Se1UrSCajzU4yLyzN5NH4tJ3tH-XA8TiUI7rRaJBuXsJAJJqsKVhbJ2tssEUjUA-4emtLdBlvHDRw1d9WqfgXMVrM4zfrkblDOri0MgDSA4RgaWavYX79CfjwY4fH-vwo-Jlvv94by3cH47QOyDYCxJrpk8Q7ZWJ6v3EMAZUv9qLa-X38CNcg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Violations+of+the+independent+increment+assumption+when+using+generalized+estimating+equation+in+longitudinal+group+sequential+trials&rft.jtitle=Statistics+in+medicine&rft.au=Shoben%2C+Abigail+B.&rft.au=Emerson%2C+Scott+S.&rft.date=2014-12-20&rft.issn=0277-6715&rft.eissn=1097-0258&rft.volume=33&rft.issue=29&rft.spage=5041&rft.epage=5056&rft_id=info:doi/10.1002%2Fsim.6306&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_sim_6306
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-6715&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-6715&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-6715&client=summon